 | • レポートコード：QYR9NV18198 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、ナチュラルキラー細胞治療薬の世界市場について調査・分析し、ナチュラルキラー細胞治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（NK細胞療法、NK細胞向け抗体）、用途別（がん、消化器疾患、免疫増殖性疾患、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のナチュラルキラー細胞治療薬市場動向 ・主要企業別マーケットシェア ・ナチュラルキラー細胞治療薬の種類別市場規模2014-2019 （NK細胞療法、NK細胞向け抗体） ・ナチュラルキラー細胞治療薬の用途別市場規模2014-2019 （がん、消化器疾患、免疫増殖性疾患、その他） ・ナチュラルキラー細胞治療薬の北米市場：主要企業・種類別/用途別市場規模 ・ナチュラルキラー細胞治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・ナチュラルキラー細胞治療薬の中国市場：主要企業・種類別/用途別市場規模 ・ナチュラルキラー細胞治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・ナチュラルキラー細胞治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・ナチュラルキラー細胞治療薬のインド市場：主要企業・種類別/用途別市場規模 ・ナチュラルキラー細胞治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Affimed、Celgene、Fate Therapeutics、Fortress Biotech、Glycostem Therapeutics、Innate Pharma、Nantkwest、Nkarta Therapeutics、NKT Therapeutics、Ziopharm Oncology） ・ナチュラルキラー細胞治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Cell therapy, a new therapeutic approach that uses a patient’s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body’s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells. In 2018, the global Natural Killer Cells Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Natural Killer Cells Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Natural Killer Cells Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Affimed
Celgene
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology
Market segment by Type, the product can be split into
NK Cell Therapies
NK Cell Directed Antibodies
Market segment by Application, split into
Cancer
Gastrointestinal Diseases
Immunoproliferative Disorders
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Natural Killer Cells Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Natural Killer Cells Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Natural Killer Cells Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 NK Cell Therapies
1.4.3 NK Cell Directed Antibodies
1.5 Market by Application
1.5.1 Global Natural Killer Cells Therapeutics Market Share by Application (2019-2025)
1.5.2 Cancer
1.5.3 Gastrointestinal Diseases
1.5.4 Immunoproliferative Disorders
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Natural Killer Cells Therapeutics Market Size
2.2 Natural Killer Cells Therapeutics Growth Trends by Regions
2.2.1 Natural Killer Cells Therapeutics Market Size by Regions (2019-2025)
2.2.2 Natural Killer Cells Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Natural Killer Cells Therapeutics Market Size by by Players
3.1.1 Global Natural Killer Cells Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Natural Killer Cells Therapeutics Key Players Head office and Area Served
3.3 Key Players Natural Killer Cells Therapeutics Product/Solution/Service
3.4 Date of Enter into Natural Killer Cells Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Natural Killer Cells Therapeutics Market Size by Type (2014-2019)
4.2 Global Natural Killer Cells Therapeutics Market Size by Application (2014-2019)
5 North America
5.1 North America Natural Killer Cells Therapeutics Market Size (2014-2019)
5.2 Natural Killer Cells Therapeutics Key Players in North America
5.3 North America Natural Killer Cells Therapeutics Market Size by Type
5.4 North America Natural Killer Cells Therapeutics Market Size by Application
6 Europe
6.1 Europe Natural Killer Cells Therapeutics Market Size (2014-2019)
6.2 Natural Killer Cells Therapeutics Key Players in Europe
6.3 Europe Natural Killer Cells Therapeutics Market Size by Type
6.4 Europe Natural Killer Cells Therapeutics Market Size by Application
7 China
7.1 China Natural Killer Cells Therapeutics Market Size (2014-2019)
7.2 Natural Killer Cells Therapeutics Key Players in China
7.3 China Natural Killer Cells Therapeutics Market Size by Type
7.4 China Natural Killer Cells Therapeutics Market Size by Application
8 Japan
8.1 Japan Natural Killer Cells Therapeutics Market Size (2014-2019)
8.2 Natural Killer Cells Therapeutics Key Players in Japan
8.3 Japan Natural Killer Cells Therapeutics Market Size by Type
8.4 Japan Natural Killer Cells Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Natural Killer Cells Therapeutics Market Size (2014-2019)
9.2 Natural Killer Cells Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Natural Killer Cells Therapeutics Market Size by Type
9.4 Southeast Asia Natural Killer Cells Therapeutics Market Size by Application
10 India
10.1 India Natural Killer Cells Therapeutics Market Size (2014-2019)
10.2 Natural Killer Cells Therapeutics Key Players in India
10.3 India Natural Killer Cells Therapeutics Market Size by Type
10.4 India Natural Killer Cells Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Natural Killer Cells Therapeutics Market Size (2014-2019)
11.2 Natural Killer Cells Therapeutics Key Players in Central & South America
11.3 Central & South America Natural Killer Cells Therapeutics Market Size by Type
11.4 Central & South America Natural Killer Cells Therapeutics Market Size by Application
12 International Players Profiles
12.1 Affimed
12.1.1 Affimed Company Details
12.1.2 Company Description and Business Overview
12.1.3 Natural Killer Cells Therapeutics Introduction
12.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2014-2019))
12.1.5 Affimed Recent Development
12.2 Celgene
12.2.1 Celgene Company Details
12.2.2 Company Description and Business Overview
12.2.3 Natural Killer Cells Therapeutics Introduction
12.2.4 Celgene Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
12.2.5 Celgene Recent Development
12.3 Fate Therapeutics
12.3.1 Fate Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Natural Killer Cells Therapeutics Introduction
12.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
12.3.5 Fate Therapeutics Recent Development
12.4 Fortress Biotech
12.4.1 Fortress Biotech Company Details
12.4.2 Company Description and Business Overview
12.4.3 Natural Killer Cells Therapeutics Introduction
12.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
12.4.5 Fortress Biotech Recent Development
12.5 Glycostem Therapeutics
12.5.1 Glycostem Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Natural Killer Cells Therapeutics Introduction
12.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
12.5.5 Glycostem Therapeutics Recent Development
12.6 Innate Pharma
12.6.1 Innate Pharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Natural Killer Cells Therapeutics Introduction
12.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
12.6.5 Innate Pharma Recent Development
12.7 Nantkwest
12.7.1 Nantkwest Company Details
12.7.2 Company Description and Business Overview
12.7.3 Natural Killer Cells Therapeutics Introduction
12.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
12.7.5 Nantkwest Recent Development
12.8 Nkarta Therapeutics
12.8.1 Nkarta Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Natural Killer Cells Therapeutics Introduction
12.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
12.8.5 Nkarta Therapeutics Recent Development
12.9 NKT Therapeutics
12.9.1 NKT Therapeutics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Natural Killer Cells Therapeutics Introduction
12.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
12.9.5 NKT Therapeutics Recent Development
12.10 Ziopharm Oncology
12.10.1 Ziopharm Oncology Company Details
12.10.2 Company Description and Business Overview
12.10.3 Natural Killer Cells Therapeutics Introduction
12.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
12.10.5 Ziopharm Oncology Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Natural Killer Cells Therapeutics Key Market Segments
Table Key Players Natural Killer Cells Therapeutics Covered
Table Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer NK Cell Therapies Figures
Table Key Players of NK Cell Therapies
Figuer NK Cell Directed Antibodies Figures
Table Key Players of NK Cell Directed Antibodies
Table Global Natural Killer Cells Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Natural Killer Cells Therapeutics Market Share by Application in 2018 & 2025
Figure Cancer Case Studies
Figure Gastrointestinal Diseases Case Studies
Figure Immunoproliferative Disorders Case Studies
Figure Others Case Studies
Figure Natural Killer Cells Therapeutics Report Years Considered
Figure Global Natural Killer Cells Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Natural Killer Cells Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Natural Killer Cells Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Natural Killer Cells Therapeutics Market Share by Regions 2014-2019
Figure Global Natural Killer Cells Therapeutics Market Share by Regions 2014-2019
Figure Global Natural Killer Cells Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Natural Killer Cells Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Natural Killer Cells Therapeutics Market Share by by Players (2014-2019)
Figure Global Natural Killer Cells Therapeutics Market Share by by Players in 2018
Table Global Natural Killer Cells Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Natural Killer Cells Therapeutics Product/Solution/Service
Table Date of Enter into Natural Killer Cells Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Natural Killer Cells Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Natural Killer Cells Therapeutics Market Size Share by Type (2014-2019)
Figure Global Natural Killer Cells Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Natural Killer Cells Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Natural Killer Cells Therapeutics Market Size Share by Application (2014-2019)
Figure Global Natural Killer Cells Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Natural Killer Cells Therapeutics Revenue Market Share by Application in 2018
Figure North America Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Natural Killer Cells Therapeutics Market Share (2018-2019)
Table North America Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Natural Killer Cells Therapeutics Market Share by Type 2014-2019
Table North America Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Natural Killer Cells Therapeutics Market Share by Application 2014-2019
Figure Europe Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Natural Killer Cells Therapeutics Market Share (2018-2019)
Table Europe Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Natural Killer Cells Therapeutics Market Share by Type 2014-2019
Table Europe Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Natural Killer Cells Therapeutics Market Share by Application 2014-2019
Figure China Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Natural Killer Cells Therapeutics Market Share (2018-2019)
Table China Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$)
Table China Natural Killer Cells Therapeutics Market Share by Type 2014-2019
Table China Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$)
Table China Natural Killer Cells Therapeutics Market Share by Application 2014-2019
Figure Japan Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Natural Killer Cells Therapeutics Market Share (2018-2019)
Table Japan Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Japan Natural Killer Cells Therapeutics Market Share by Type 2014-2019
Table Japan Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Japan Natural Killer Cells Therapeutics Market Share by Application 2014-2019
Figure Southeast Asia Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Natural Killer Cells Therapeutics Market Share (2018-2019)
Table Southeast Asia Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Natural Killer Cells Therapeutics Market Share by Type 2014-2019
Table Southeast Asia Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Natural Killer Cells Therapeutics Market Share by Application 2014-2019
Figure India Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Natural Killer Cells Therapeutics Market Share (2018-2019)
Table India Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$)
Table India Natural Killer Cells Therapeutics Market Share by Type 2014-2019
Table India Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$)
Table India Natural Killer Cells Therapeutics Market Share by Application 2014-2019
Figure Central & South America Natural Killer Cells Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Natural Killer Cells Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Natural Killer Cells Therapeutics Market Share (2018-2019)
Table Central & South America Natural Killer Cells Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Central & South America Natural Killer Cells Therapeutics Market Share by Type 2014-2019
Table Central & South America Natural Killer Cells Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Central & South America Natural Killer Cells Therapeutics Market Share by Application 2014-2019
Table Affimed Company Details
Table Affimed Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$)
Figure Affimed Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019)
Table Affimed Recent Development
Table Celgene Company Details
Table Celgene Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$)
Figure Celgene Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019)
Table Celgene Recent Development
Table Fate Therapeutics Company Details
Table Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$)
Figure Fate Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019)
Table Fate Therapeutics Recent Development
Table Fortress Biotech Company Details
Table Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$)
Figure Fortress Biotech Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019)
Table Fortress Biotech Recent Development
Table Glycostem Therapeutics Company Details
Table Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$)
Figure Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019)
Table Glycostem Therapeutics Recent Development
Table Innate Pharma Company Details
Table Innate Pharma Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$)
Figure Innate Pharma Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019)
Table Innate Pharma Recent Development
Table Nantkwest Company Details
Table Nantkwest Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$)
Figure Nantkwest Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019)
Table Nantkwest Recent Development
Table Nkarta Therapeutics Company Details
Table Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$)
Figure Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019)
Table Nkarta Therapeutics Recent Development
Table NKT Therapeutics Company Details
Table NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$)
Figure NKT Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019)
Table NKT Therapeutics Recent Development
Table Ziopharm Oncology Company Details
Table Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business 2014-2019 (Million US$)
Figure Ziopharm Oncology Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2014-2019)
Table Ziopharm Oncology Recent Development
Table Global Natural Killer Cells Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Natural Killer Cells Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Natural Killer Cells Therapeutics Market Size Share by Regions in 2025
Figure North America Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Natural Killer Cells Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Natural Killer Cells Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Natural Killer Cells Therapeutics Market Size by Product (2019-2025)
Figure Global Natural Killer Cells Therapeutics Market Size by Product in 2025
Table Global Natural Killer Cells Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Natural Killer Cells Therapeutics Market Size by Application (2019-2025)
Figure Global Natural Killer Cells Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ナチュラルキラー細胞治療薬のグローバル市場：規模・現状・予測2019-2025 Cell therapy, a new therapeutic approach that uses a patient’s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body’s first line of defense against infections and diseases with an innate ability to rapidly seek and destr…- 世界のナチュラルキラー細胞療法産業調査2019-2025 Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment.In 2018, the global Natural Killer Cell Therapies market size was xx million US$ and is forecast to xx million US in 2025, grow…
- 世界のナチュラルキラー細胞療法産業調査2019-2025 Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment.In 2018, the global Natural Killer Cell Therapies market size was xx million US$ and is forecast to xx million US in 2025, grow…
- B細胞成熟抗原（BCMA）標的療法のグローバル市場調査 2019年 The global B-Cell Maturation Antigen(BCMA) Targeted Therapies market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on B-Cell Maturation Antigen(BCMA) Targeted Therapies volume and value at global level, reg…
- がん幹細胞の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. Scope of the Report: This report studies the Cancer St…